The PREVAILS study, now fully enrolled, marks a critical step toward simultaneous regulatory submissions in China and Europe for the next-generation TAVR system
Home
Immediapress
Pr Newswire
Comunicato stampa - contenuto promozionale
Responsabilità editoriale PrNewswire
FRANKFURT, Germany and HANGZHOU, China, June 24, 2026 /PRNewswire/ -- Valgen Medtech recently announced that its proprietary…
Company Enters the Second Half of 2026 With Tailwinds From an FDA IDE Approval, With the TAVVE Pivotal Study Expected to Begin…
Company highlights international growth strategy, expanding structural heart portfolio, and commercialization priorities
GOTHENBURG, SE / ACCESS Newswire / August 3, 2026 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) - XVIVO announces that the…
Penumbra Expands CAVT for Stroke to Europe with CE Mark for THUNDERBOLT
Ventric Health's Vivio® System Demonstrates High Scalability and Operational Feasibility for Population-Level Heart Failure…
